• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包含不同细胞依赖性和AP-1反应模块的88个核苷酸增强子对人乳头瘤病毒16型P97启动子的转录激活作用。

Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.

作者信息

Cripe T P, Alderborn A, Anderson R D, Parkkinen S, Bergman P, Haugen T H, Pettersson U, Turek L P

机构信息

Department of Pathology, Veterans Administration Medical Center, Iowa City, IA.

出版信息

New Biol. 1990 May;2(5):450-63.

PMID:1963084
Abstract

The P97 promoter upstream of the oncogenic early genes of human papillomavirus (HPV)-16 is active in keratinocytes and in cervical carcinoma cells due to a 5' keratinocyte-dependent cis enhancer. In this study, we have mapped the main enhancer activity to an 88-nucleotide (nt) fragment composed of multiple cis elements. A 63-nt promoter-proximal enhancer core was sufficient for P97 activation in a human keratinocytic cell line, HaCaT, and in cervical carcinoma cells. Although the enhancer functioned poorly in hepatoma cells or in fibroblasts, nuclear extracts from different cells protected similar cis elements from DNase I digestion. Two protected half-palindromic NF-I/CTF sites within the 63-nt core were necessary for its function; one represents a "cytokeratin element" (CK), a previously described 8-nt sequence shared with cytokeratin gene promoters. Both sites formed complexes of the same apparent size and relative binding affinity with NF-I/CTF-like factor(s) present in all cells tested. Although cell-dependent P97 activation could be determined by similar, yet distinct NF-I/CTF-like proteins, adjacent cis elements in the enhancer core were also required for function, and may thus interact with additional transcription factors. A 25-nt distal module with two AP-1 sites increased enhancer activity and cooperated with cis elements of the proximal core. Each AP-1 site as well as a third AP-1 site near the promoter bound c-Jun and Jun/Fos in vitro, and was activated by c-Jun and c-Fos in transfections. In addition to cell type-dependent activation, HPV-16 P97 transcription may therefore respond to growth factors and oncogene products via the AP-1 pathway.

摘要

人乳头瘤病毒(HPV)-16致癌早期基因上游的P97启动子在角质形成细胞和宫颈癌细胞中具有活性,这归因于一个5'端依赖角质形成细胞的顺式增强子。在本研究中,我们已将主要的增强子活性定位到一个由多个顺式元件组成的88个核苷酸(nt)的片段上。一个63 nt的启动子近端增强子核心足以在人角质形成细胞系HaCaT和宫颈癌细胞中激活P97。尽管该增强子在肝癌细胞或成纤维细胞中功能不佳,但来自不同细胞的核提取物能保护相似的顺式元件不被DNase I消化。63 nt核心区域内的两个受保护的半回文NF-I/CTF位点对其功能是必需的;其中一个代表“细胞角蛋白元件”(CK),这是一个先前描述的与细胞角蛋白基因启动子共有的8 nt序列。这两个位点与所有测试细胞中存在的NF-I/CTF样因子形成大小和相对结合亲和力相同的复合物。尽管细胞依赖性的P97激活可由相似但不同的NF-I/CTF样蛋白决定,但增强子核心中的相邻顺式元件对其功能也是必需的,因此可能与其他转录因子相互作用。一个带有两个AP-1位点的25 nt远端模块增强了增强子活性,并与近端核心的顺式元件协同作用。每个AP-1位点以及启动子附近的第三个AP-1位点在体外与c-Jun和Jun/Fos结合,并在转染中被c-Jun和c-Fos激活。因此,除了细胞类型依赖性激活外,HPV-16 P97转录可能通过AP-1途径对生长因子和癌基因产物作出反应。

相似文献

1
Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.包含不同细胞依赖性和AP-1反应模块的88个核苷酸增强子对人乳头瘤病毒16型P97启动子的转录激活作用。
New Biol. 1990 May;2(5):450-63.
2
A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines.16型人乳头瘤病毒(HPV 16)-P97启动子的细胞类型特异性转录增强子是通过人上皮细胞系中与HPV相关的细胞事件来定义的。
Virology. 1993 Aug;195(2):500-10. doi: 10.1006/viro.1993.1401.
3
Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.显性负性Jun的表达可抑制升高的AP-1和NF-κB反式激活,并抑制人乳头瘤病毒永生化人角质形成细胞的锚定非依赖性生长。
Oncogene. 1998 May 28;16(21):2711-21. doi: 10.1038/sj.onc.1201798.
4
Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.人类粒细胞-巨噬细胞集落刺激因子基因启动子在T细胞中发挥功能需要多种信号。
J Immunol. 1995 Aug 1;155(3):1240-51.
5
A distal element in the HPV-11 upstream regulatory region contributes to promoter repression in basal keratinocytes in squamous epithelium.人乳头瘤病毒11型上游调控区的一个远端元件有助于鳞状上皮基底角质形成细胞中的启动子抑制。
Virology. 1999 Jan 20;253(2):219-29. doi: 10.1006/viro.1998.9478.
6
Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.人乳头瘤病毒31b型增强子的转录活性通过AP1与两种新型细胞因子的协同相互作用来调节。
Virology. 1995 Aug 1;211(1):184-97. doi: 10.1006/viro.1995.1390.
7
Transcriptional control and cell type specificity of HPV gene expression.人乳头瘤病毒基因表达的转录调控与细胞类型特异性
Arch Dermatol. 1994 Feb;130(2):210-5.
8
Purification of the 120 kDa component of the human nuclear factor of activated T cells (NF-AT): reconstitution of binding activity to the cis-acting element of the GM-CSF and IL-2 promoter with AP-1.人活化T细胞核因子(NF-AT)120 kDa组分的纯化:与AP-1一起重建对GM-CSF和IL-2启动子顺式作用元件的结合活性。
Biochem Biophys Res Commun. 1993 Oct 29;196(2):737-44. doi: 10.1006/bbrc.1993.2311.
9
Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.亚致死水平的氧化应激刺激Jurkat T细胞中c-jun的转录激活并抑制IL-2启动子的激活。
J Immunol. 1996 Jul 1;157(1):160-9.
10
Transcription of Djun from D. melanogaster is positively regulated by DTF-1, AP-1, and CREB binding sites.来自黑腹果蝇的Djun的转录受到DTF-1、AP-1和CREB结合位点的正向调控。
Exp Cell Res. 1994 Sep;214(1):389-99. doi: 10.1006/excr.1994.1272.

引用本文的文献

1
Exploitation of ATP-sensitive potassium ion (K) channels by HPV promotes cervical cancer cell proliferation by contributing to MAPK/AP-1 signalling.HPV 对 ATP 敏感性钾离子 (K) 通道的利用促进了 MAPK/AP-1 信号通路,从而促进了宫颈癌细胞的增殖。
Oncogene. 2023 Aug;42(34):2558-2577. doi: 10.1038/s41388-023-02772-w. Epub 2023 Jul 13.
2
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.MEK/ERK 信号通路是高危型人乳头瘤病毒致癌基因表达的关键调节因子,为 HPV 诱导肿瘤的治疗靶点提供了新的思路。
PLoS Pathog. 2021 Jan 22;17(1):e1009216. doi: 10.1371/journal.ppat.1009216. eCollection 2021 Jan.
3
High-Risk Human Papillomavirus and Tobacco Smoke Interactions in Epithelial Carcinogenesis.
高危型人乳头瘤病毒与烟草烟雾在上皮细胞癌变中的相互作用
Cancers (Basel). 2020 Aug 6;12(8):2201. doi: 10.3390/cancers12082201.
4
Regulation of HPV transcription.人乳头瘤病毒转录的调控
Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e486s. doi: 10.6061/clinics/2018/e486s.
5
Post-Transcriptional Regulation of KLF4 by High-Risk Human Papillomaviruses Is Necessary for the Differentiation-Dependent Viral Life Cycle.高危型人乳头瘤病毒对KLF4的转录后调控是依赖分化的病毒生命周期所必需的。
PLoS Pathog. 2016 Jul 7;12(7):e1005747. doi: 10.1371/journal.ppat.1005747. eCollection 2016 Jul.
6
Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.c-Jun与Fra-2/c-Fos的选择性参与促进舌癌的侵袭性肿瘤表型和不良预后。
Sci Rep. 2015 Nov 19;5:16811. doi: 10.1038/srep16811.
7
Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer.姜黄素可调节口腔癌中的细胞AP-1、NF-κB和HPV16 E6蛋白。
Ecancermedicalscience. 2015 Apr 23;9:525. doi: 10.3332/ecancer.2015.525. eCollection 2015.
8
Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.分化依赖性变化的 C/EBPβ 抑制剂和激活剂调节人乳头瘤病毒 31 型晚期基因表达。
J Virol. 2012 May;86(9):5393-8. doi: 10.1128/JVI.07239-11. Epub 2012 Feb 29.
9
Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.激活蛋白-1 驱动的人乳头瘤病毒染色质依赖性转录中的结合位点特异性和因子冗余。
J Biol Chem. 2011 Nov 25;286(47):40974-86. doi: 10.1074/jbc.M111.290874. Epub 2011 Sep 21.
10
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.β-干扰素治疗通过激活干扰素调节因子(IRF)-1增加人乳头瘤病毒早期基因转录和病毒质粒基因组复制。
Carcinogenesis. 2009 Aug;30(8):1336-44. doi: 10.1093/carcin/bgp150. Epub 2009 Jun 18.